Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience-Reference-Cited by-同舟云学术

Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience

Published:2024-07-01 Issue:7 Volume:34 Page:949-952
ISSN:1050-7256
Container-title:Thyroid®
language:en
Short-container-title:Thyroid®

Author:

Pitoia Fabián¹^ORCID,Abelleira Erika¹,Román-González Alejandro²,Danilovic Debora L. S.³^ORCID,Scheffel Rafael Selbach⁴,Maia Ana Luiza⁴,Hoff Ana O.⁵,Califano Inés⁶^ORCID

Affiliation:

1. Hospital de Clínicas “José de San Martín” University of Buenos Aires, Buenos Aires, Argentina.

2. Hospital San Vicente Fundación-Universidad de Antioquia, Medellín, Colombia.

3. Laboratorio de Endocrinologia Celular e Molecular (LIM25), Hospital das Clinicas HCFMUSP, Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil.

4. Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

5. Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paulo, São Paulo, Brazil.

6. Instituto de Oncología “Angel H. Roffo” University of Buenos Aires, Buenos Aires, Argentina.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2024.0090

Reference10 articles.

1. Management of invasive well-differentiated thyroid cancer: An American head and neck society consensus statement: AHNS consensus statement

2. Establishment and validation of a nomogram model for predicting distant metastasis in medullary thyroid carcinoma: An analysis of the SEER database based on the AJCC 8th TNM staging system

3. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

4. A phase 2 study of neoadjuvant lenvatinib in locally advanced invasive thyroid cancer.

5. Efficacy of Selpercatinib in RET-Altered Thyroid Cancers